In severe obesity, excessive adiposity alters this gut-liver axis, potentially disrupting hepatocyte-mediated regulation of FGF19, an enterokine produced in the ileum in response to bile acid signaling [15,16,17,18,19,20,21,22,23,29,30]. This evidence concerns the gene FGF19 and obesity disorder.